Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan and Simmitecan, 5-fluorouracil and Leucovorin Calcium, in Patients With Advanced Solid Tumors

Next Previous
X
Search
Trial Profile

Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan and Simmitecan, 5-fluorouracil and Leucovorin Calcium, in Patients With Advanced Solid Tumors

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Simmitecan (Primary) ; Fluorouracil; Folinic acid; Thalidomide
  • Indications Biliary cancer; Carcinoma; Colorectal cancer; Gallbladder cancer; Gastric cancer; Gastrointestinal cancer; Gastrointestinal stromal tumours; Liver cancer; Neuroendocrine carcinoma; Oesophageal cancer; Pancreatic cancer; Solid tumours
  • Focus Pharmacokinetics
  • Sponsors Haihe Biopharma; ShangHai HaiHe Pharmaceutical

    • Most Recent Events

    • 31 May 2020 Results (n=41) assessing safety and efficacy presented at the 56th Annual Meeting of the American Society of Clinical Oncology
    • 18 Jul 2017 Number of arms of the study has increased from 4 to 6,hence number of planned patient number has also changed from 153 to243.
    • 11 Jul 2017 Planned number of patients changed from 158 to 243.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top